The neurobiology and treatment of restless legs syndrome

Behavioural Neurology

Volumn 26, Issue 4, 2013, Pages 283-292

  Jones, Ruth ^a   Cavanna, Andrea Eugenio ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dopamine; iron; opioids; pathophysiology; pharmacotherapy; restless legs syndrome

Indexed keywords

3 OTHRO METHYL DOPA; BETA ENDORPHIN; DOPAMINE; ENDORPHIN; ENKEPHALIN; ERGOT DERIVATIVE; FERRITIN; GABAPENTIN; GABAPENTIN ENACARBIL; HOMOVANILLIC ACID; IRON; LAMOTRIGINE; LEUCINE ENKEPHALIN; LEVODOPA; METENKEPHALIN; NALOXONE; OPIATE; OPIATE RECEPTOR; OXIDOPAMINE; PLACEBO; PRAMIPEXOLE; PREGABALIN; ROPINIROLE; ROTIGOTINE; TETRAHYDROBIOPTERIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPSY; BASAL GANGLION; BEHAVIOR CHANGE; CEREBROSPINAL FLUID ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE MODEL; DIZZINESS; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DYSKINESIA; FLUID RETENTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INSOMNIA; IRON DEFICIENCY; IRON THERAPY; NAUSEA; NEUROANATOMY; NEUROBIOLOGY; NEUROIMAGING; NEUROPATHOLOGY; NEUROPATHY; NONHUMAN; PATHOLOGICAL ANATOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOMNOLENCE; SYSTEMATIC REVIEW;

EID: 84876218693     PISSN: 09534180     EISSN: 18758584     Source Type: Journal    
DOI: 10.3233/BEN-2012-120271     Document Type: Article

References (47)

1. C.J. Earley, Restless Legs Syndrome, The New England Journal of Medicine 348 (2003), 2103-2109. (Pubitemid 36583306)
2. P. Agarwal, A. Griffith, H.R. Costantino and N. Vaish, Gabapentin enacarbil-clinical efficacy in restless legs syndrome, Neuropsychiatric Disease and Treatment 6 (2010), 151-158.
3. P. Satija andW.G.Ondo, Restless Legs Syndrome: Pathophysiology, Diagnosis and Treatment, CNS Drugs 22(6) (2008), 497-518. (Pubitemid 351693691)
4. C. Trenkwalder andW. Paulus, Restless legs syndrome: pathophysiology, clinical presentation andmanagement, Nature Reviews Neurology 6 (2010), 337-346.
5. R.E. Salas, G.E. Gamaldo and R.P. Allen, Update in restless legs syndrome, Current Opinion in Neurology 23(4) (2010), 401-406.
6. M. Miyamoto, T. Miyamoto, M. Iwanami, K. Suzuki and K. Hirata, Pathophysiology of restless legs syndrome, Brain and Nerve 61(5) (2009), 523-532.
7. R.P.Allen and C.J. Earley, Restless Legs Syndrome: AReview of Clinical and Pathophysiologic Features, Journal of Clinical Neurophysiology 18(2) (2001), 128-147. (Pubitemid 32549908)
8. S.Akpinar, Treatment of restless legs syndrome with levodopa plus benserazide, Archives of Neurology 39(11) (1982), 739.
9. R.P. Allen, in: Neurobiology of Disease, Gillman; Elsevier Academic Press: London, 2007, pp. 723-735.
10. C.E. Gamaldo and C.J. Earley, Restless Legs Syndrome A Clinical Update, CHEST 130(5) (2006), 1596-1604. (Pubitemid 44786758)
11. J.W. Winkelman, Considering the causes of RLS, European Journal of Neurology 13(S3) (2006), 8-14.
12. T.C.Wetter, I. Eisensehr and C. Trenkwalder, Functional neuroimaging studies in restless legs syndrome, Sleep Medicine 5(4) (2004), 401-406. (Pubitemid 38842741)
13. C. Trenkwalder, A.S. Walters, W.A. Hening, S. Chokroverty, A. Antonini, V. Dhawan and D. Eidelberg, Positron emission tomographic studies in restless legs syndrome, Movement Disorders 14(1) (1999), 141-145. (Pubitemid 29224690)
14. N. Turjanski, A.J. Lees and D.J. Brooks, Striatal dopaminergic function in restless legs syndrome 18F-dopa and 11Craclopride PET studies, Neurology 52(5) (1999), 932.
15. H.M. Ruottinen, M. Partinen, C. Hublin, J. Bergman, M. Haaparanta, O. Solin and J.O. Rinne, An FDOPA PET study in patents with periodic limbmovement disorder and restless legs syndrome, Neurology 54(2) (2000), 502.
16. S. Cervenka, S.E. Palhagen, R.A. Comley, G. Panagiotidis, Z. Cseĺenyi, J.C. Matthews, R.Y. Lai, C. Halldin and L. Farde, Support for dopaminergic hypoactvity in restless legs syndrome: a PET study on D2-receptor binding, Brain 129(8) (2006), 2017-2028. (Pubitemid 44289067)
17. J. Staedt, G. Stoppe, A. K̈ogler, H. Riemann, G. Hajak, D.L. Munz, D. Emrich and E. R̈uther, Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration, European Archives of Psychiatry and Clinical Neuroscience 245(1) (1995), 8-10.
18. M. Michaud, J.P. Soucy, A. Chabli, G. Lavigne and J. Montplaisir, SPECT imaging of striatal pre-and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep, Journal of Neurology 249(2) (2002), 164-170. (Pubitemid 34143470)
19. I. Eisensehr, T.C. Wetter, R. Linke, S. Noachtar, H.V. Lindeiner, F.J. Gildehaus, C. Trenkwalder and K. Tatsch, Normal IPT and IBZM SPECT in drug-näve and levodopa-treated idiopathic restless legs syndrome, Neurology 57(7) (2001), 1307-1309. (Pubitemid 32947394)
20. G.G. Tribl, A. Asenbaum, G. Kl̈osch, K.Mayer, R.M. Bonelli, E. Auff and J. Zeitlhofer, Normal IPT and IBZM SPECT in drug näve and levodopa-treated idiopathic restless legs syndrome, Neurology 59(4) (2002), 649-650. (Pubitemid 34920017)
21. W.G. Ondo,Y. He, S. Rajasekaran andW.D. Le, Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: A possible model for restless legs syndrome? Movement Disorders 15(1) (2000), 154-158. (Pubitemid 30038003)
22. K. Stiasny-Kolster, J. Carsten M̈oller, J. Zschocke, O. Bandmann, W. Cassel, W.H. Oertel and G.F. Hoffmann, Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients, Movement Disorders 19(2) (2004), 192-196. (Pubitemid 38312702)
23. C.J. Earley, K. Hyland and R.P. Allen, Circadian changes in CSF dopaminergic measures in restless legs syndrome, Sleep Medicine 7(3) (2006), 263-268.
24. R.P. Allen, J.R. Connor, K. Hyland and C. Earley, Abnormally increased CSF 3-Ortho-methydopa (3OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis, Sleep Medicine 10(1) (2009), 123-128.
25. J.R. Connor, X.S. Wang, R.P. Allen, J.L. Beard, J.A. Wiesinger, B.T. Felt and C.J. Earley, Altered dopaminergic profile in the putamen and substantia nigra in restless legs syndrome, Brain 132(9) (2009), 2403-2412.
26. C.J. Earley, R.P. Allen, J.R. Connor, L. Ferrucci and J. Troncoso, The dopaminergc neurons of the A11 system in RLS autopsy brains appear normal, Sleep Medicine 10(10) (2009), 1155-1157.
27. J.R. Connor, P. Ponnuru, X.S. Wang, S.M. Patton, R.P. Allen and C.J. Earley, Profile of altered brain iron acquisition in restless legs syndrome, Brain 134(4) (2011), 959-968.
28. Q. Chen, J.L. Beard and B.C. Jones, Abnormal rat brain monoamine metabolism in iron deficiency anemia, The Journal of Nutritional Biochemistry 6(9), 486-493.
29. C.J. Earley, J.R. Connor, J.L. Beard, E.A. Malecki, D.K. Epstein and R.P. Allen, Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome, Neurology 54(8) (2000), 1698-1700. (Pubitemid 30226823)
30. J.R. Connor, P.J. Boyer, S.L.Menzies, B.Dellinger, R.P.Allen, W.G. Ondo and C.J. Earley, Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome, Neurology 61(3) (2003), 304-309. (Pubitemid 36975956)
31. J.R. Connor, X.S.Wang, S.M. Patton, S.L. Menzies, J.C. Troncoso, C.J. Earley and R.P. Allen, Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome, Neurology 62(9) (2004), 1563-1567. (Pubitemid 38608196)
32. X.Wang, J.Wiesinger, J. Beard, B. Felt, S.Menzies, C. Earley, R. Allen and J. Connor, Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome, Journal of the Neurological Sciences 220 (2004), 59-66. (Pubitemid 38622099)
33. S. Mizuno, T. Mihara, T.Miyaoka, T. Inagaki and J.Horiguchi, CSF iron, ferritin and transferrin levels in restless legs syndrome, Journal of Sleep Research 14 (2005), 43-47. (Pubitemid 40396070)
34. C. Schmidaeur, M. Sojer, K. Seppi, H. Stockner, B. Ḧogl, B. Biedermann, E. Brandaeur, C.M. Peralta, G.K. Wenning and W. Poewe, Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome, Annals of Neurology 58(4) (2005), 630-634. (Pubitemid 41377229)
35. C.J. Earley, P.B. Barker, A. Horska and R.P. Allen, MRIdetermined regional brain iron concentrations in early-and late-onset restless legs syndrome, Sleep Medicine 7(5) (2006), 458-461. (Pubitemid 44164164)
36. W.A. Hening, A. Walters, N. Kavey, G. Gidro-Frank, L. Ĉot́e and S. Fahn, Dyskinesias while awake and periodic movements in sleep in restless legs syndrome. Treatment with opioids, Neurology 36(10) (1986), 1363.
37. A. Walters, W. Hening, L. Ĉot́e and S. Fahn, Dominantly inherited restless legs with myoclonus and periodic movements of sleep: a syndrome related to the endogenous opiates? Advances in Neurology 43 (1986), 309-319.
38. A.S. Walters, W.G. Ondo, W. Zhu and Le. Weidong, Does the endogenous opiate system play a role in the Restless Legs Syndrome?: A pilot post-mortem study, Journal of the Neurological Sciences 279 (2009), 62-65.
39. V. Von Spiczak, A.L. Whone, A. Hammers, M.C. Asselin, F. Turkheimer, T. Tings, S. Happe, W. Paulus, C. Trenkwalder and D.J. Brooks, The role of opioids in restless legs syndrome: an (11C)diprenorphine PET study, Brain 128(4) (2005), 906-917. (Pubitemid 40516927)
40. C. Trenkwalder, W. Paulus and A.S.Walters, The restless legs syndrome, Lancet Neurology 4 (2005), 465-475. (Pubitemid 40982457)
41. W. Hening, R. Allen, C. Earley, C. Kushida, D. Picchietti and M. Silber, The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review, Sleep 22(7) (1999), 970-999. (Pubitemid 29526518)
42. W.A. Hening, R.P. Allen, C.J. Earley, D.L. Picchetti and M.H. Silber, An Update on the Dopaminergic Treatment of Restless Legs Syndrome and Periodic LimbMovement Disorder, Sleep 27(3) (2004), 560-583. (Pubitemid 44138822)
43. R. Jones, H. Rickards and A.E. Cavanna, Gabapentin Enacarbil: Pharmacotherapy of Restless Legs Syndrome, Journal of Central Nervous System Disease 2 (2010), 45-55.
44. G. Barrìere, J.R. Cazalets, B. Bioulac, F. Tison and I. Ghorayeb, The restless legs syndrome, Progress in Neurobiology 77(3) (2005), 139-165. (Pubitemid 41677621)
45. C. Trenkwalder and W. Paulus, Why do restless legs occur at rest?-pathophysiology of neuronal structures in RLS. Neurophysiology of RLS (part 2), Clinical Neurophysiology 115 (2004), 1975-1988. (Pubitemid 39037286)
46. J.Montplaisir, R.P. Allen, A.S.Walters and L. Ferini-Strambi, in: Principles and Practice of Sleep Medicine, (Kryger, 4th ed.), Elsevier Saunders: Philadelphia, 2005, pp. 839-852.
47. L.R. Patrick, Restless legs syndrome: pathophysiology and the role of iron and folate, Alternative Medicine Review: a Journal of Clinical Therapeutic 12(2) (2007), 101-112.